Tiziana and Renaissance will partner to accelerate clinical development and potential commercial launch of nasal foralumab.

Long COVID is a complex and often debilitating complication following COVID-19 infection. It affects millions worldwide, presenting with symptoms such as persistent fatigue, cognitive impairment ...

designed for intranasal administration. The open-label study assessed safety, tolerability and efficacy of the compound at a single 10mg dose, alongside psychological support, in patients with ...

H1N1 Vaccines Market H1N1 Vaccines Market Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "H1N1 Vaccines Market Analysis by ...

About 45% of children who receive intranasal midazolam for laceration repair do not respond to the medication and demonstrate ...

In a recent publication in Cell, researchers from the National University of Singapore and collaborators have proposed using commensal bacteria in the nasal cavity as a delivery vector for precision ...

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions, today announced its participation at the Emergencies ...

has entered into a product development services agreement with Renaissance Lakewood LLC to enhance and scale up the formulation of its lead candidate, intranasal foralumab, a fully human anti-CD3 ...

Alternative dosing routes, such as rectal and intranasal (IN) routes, have been suggested as options for oral or intravenous administration. Rhinitis and pharmacological agents used for treatment ...

More information: Kristy K L Coleman et al, Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive ...

Oragenics (OGEN) announced its participation at the Emergencies in Medicine Conference, where Dr. James Kelly, Chief Medical Officer and ...

View Full Profile. Learn about our Editorial Policies. With rare exceptions like the oral polio vaccine and intranasal vaccines against influenza, the majority of immunizations are administered ...